Thrombomodulin resistance as a novel prothrombotic pathway in COVID-19

Abstract Hypercoagulability and endothelial dysfunction are strongly involved in the worsening of the clinical condition in COVID-19 patients. In severe cases, the inflammatory process triggers the release of angiopoietin 2, which could decrease circulating thrombomodulin (TM), a major regulatory me...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Ana Marco-Rico, Adrián Montaño, Francisco López-Jaime, Ihosvany Fernández-Bello, Pascual Marco-Vera
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Nature Portfolio 2025-08-01
Цуврал:	Scientific Reports
Нөхцлүүд:	COVID-19 Thrombosis Thrombin generation Thrombomodulin resistance Severe clinical events
Онлайн хандалт:	https://doi.org/10.1038/s41598-025-15679-1
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!